Physician

Gary Gordon, M.D.

According to 2025 Medicare claims, Gary Gordon, M.D. (NPI: 1225065774) practices rheumatology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (NPI: 1841226099; TIN: 23-1714249) and primary practice location at 19010-3200. Gordon is affiliated with the Aledade 101 Regional MSSP (ACO ID: A5216) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gordon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 663 traditional Medicare patients, billed 157,753 HCPCS/CPT codes, and received $1,552,177 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,893 prescription claims across 449 beneficiaries totaling $2,701,683 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 203 records totaling $6,081. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $255,460 to $1,552,177. Similarly, Part D prescription costs have risen steadily, from $1,541,383 to $2,701,683. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	732	7,967	$255,460
2016	724	9,560	$305,583
2017	691	13,692	$378,578
2018	691	16,941	$354,170
2019	624	12,263	$253,990
2020	669	31,735	$654,062
2021	896	104,644	$1,831,131
2022	714	124,950	$1,627,491
2023	653	129,523	$1,371,895
2024	663	157,753	$1,552,177

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	340	1,474	$1,541,383
2016	387	1,583	$1,436,315
2017	380	1,523	$839,202
2018	368	1,510	$1,261,033
2019	350	1,456	$1,171,239
2020	369	1,561	$1,396,948
2021	407	1,658	$1,583,834
2022	359	1,663	$2,144,530
2023	411	1,701	$2,261,690
2024	449	1,893	$2,701,683

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	110	110	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	385	661	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	230	301	$69
J0897	Injection, denosumab, 1 mg	145	14,700	$21
96372	Injection of drug or substance under skin or into muscle	189	692	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	53	1,512	$372,420
Rinvoq	Upadacitinib	55	1,710	$364,461
Enbrel Sureclick	Etanercept	39	1,092	$298,352
Enbrel	Etanercept	22	840	$298,170
Humira(Cf)	Adalimumab	23	924	$275,771

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	203	$6,081	Mallinckrodt Hospital Products Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gary Gordon, M.D.?

Tedicare shows public-source Medicare data for Gary Gordon, M.D. (NPI 1225065774), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gary Gordon, M.D. have ACO affiliation data?

Gary Gordon, M.D. is shown with ACO affiliation data for Aledade 101 Regional MSSP (MSSP, ACO ID A5216) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Gary Gordon, M.D.?

Gary Gordon, M.D. is linked to BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (billing NPI 1841226099) in the available physician profile data.

Does Gary Gordon, M.D. have Open Payments data?

Gary Gordon, M.D. has 203 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.